A Study to Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Children (Substudy B)
A Master Phase 1/2/3 Protocol to Investigate the Safety, Tolerability, and Immunogenicity of Variant-Adapted BNT162b2 RNA-Based Vaccine Candidate(s) in Healthy Children
Category & Conditions: Vaccine-related Conditions
Medicine: PF-07302048 (BNT162)
ClinicalTrials.gov Identifier (NCT): NCT05543616
Protocol ID: C4591048 SSB
Open Plain Language Summary Result:
Click here